Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer

Krushna C. Patra(University of Illinois Chicago), Qi Wang(University of Illinois Chicago), Prashanth T. Bhaskar(University of Illinois Chicago), Luke Miller(University of Illinois Chicago), Zebin Wang(University of Illinois Chicago), Will Wheaton(Northwestern University), Navdeep S. Chandel(Northwestern University), Markku Laakso(University of Eastern Finland), William J. Muller(McGill University Health Centre), Eric L. Allen(Agios Pharmaceuticals (United States)), Abhishek Jha(Agios Pharmaceuticals (United States)), Gromoslaw A. Smolen(Agios Pharmaceuticals (United States)), Michelle Clasquin(Agios Pharmaceuticals (United States)), R. Brooks Robey(Dartmouth College), Nissim Hay(University of Illinois Chicago)
Cancer Cell
August 1, 2013
Cited by 851Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis